Paul R. Rosie

Paul Rosie is a partner in the firm’s Technology group. His practice focuses on general corporate representation, venture capital financings, mergers and acquisitions, public offerings and SEC compliance. Paul counsels emerging growth companies at all stages of maturity, including formation, initial funding, expansion and exit. He also represents venture capital funds and investment banks focusing on technology and healthcare. Paul originally joined Goodwin in 2015.

Paul’s client representations include:

Mergers and Acquisitions

• Abide Therapeutics in its sale to Lundbeck
• Allurion Technologies in its business combination with SPAC Compute Health Acquisition Corp.
• Bend Financial in its sale to Webster Financial Corporation
• HealthEdge in its sale to Blackstone
• Helio Vision in its sale to Aldeyra Therapeutics
• iRobot Corporation in its acquisitions of Aeris Cleantec AG and Robopolis SAS
• LumiraDx in its business combination with SPAC CA Healthcare Acquisition Corp.
• Mitralign in its sale to Edwards Lifesciences Corporation

Private Financings

• Allurion Technologies in its preferred stock financings
• Arccos Golf in its $20 million Series C financing
• COTA in its equity and debt financings
• Health Data Analytics Institute in its $31 million Series C financing
• Labviva in its $20M Series A financing
• Outcomes4Me in its $12M Series A financing
• Tomorrow.io in its preferred stock financings, including its $87 million Series E financing
• Zus Health in its $34M Series A financing

Public Offerings

• argenx SE in its $115 million initial U.S. public offering
• BeiGene, Ltd. in its $200 million, $201 million and $800 million follow-on public offerings
• Proteostasis Therapeutics, Inc. in its $40 million follow-on public offering
• Underwriters in Flywire’s $256 million follow-on public offering
• Underwriters in Ibex Limited’s $90 million initial public offering
• Underwriters in Oscar Health’s $1.4 billion initial public offering

Paul holds office hours at the Harvard Innovation Lab and he has served as a mentor for the MIT $100K Entrepreneurship Competition.

Paul rejoined Goodwin in 2018 after serving as a senior corporate counsel at Pegasystems, where he worked on SEC compliance, mergers and acquisitions, and its corporate venture program. Prior to joining the firm, Paul served as a senior corporate counsel at athenahealth, where he advised on corporate governance and securities matters, mergers and acquisitions, and the launch of athenahealth’s More Disruption Please innovation and partnership program.